David Kirn Insider Trades & Stock Holdings

President and Chief Executive Officer · 4D Molecular Therapeutics, Inc. · Latest filing Jun 22, 2026

David Kirn, President and Chief Executive Officer at 4D Molecular Therapeutics, Inc. has 1 Form 4 trade on file since Jun 22, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($1.20M), net -$1.20M. Latest filing: disposed of 114.75K shares of $FDMT on Jun 22, 2026 at $10.47.

Trades on file

1

Open-market bought

$0

Open-market sold

$1.20M

Net open-market

-$1.20M

Latest filing

Jun 22, 2026

All insider trades by David Kirn

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 22, 2026	$FDMT	Sell (Open-market sale) 10b5-1	114.75K	$10.47	$1.20M			+23.6%	+5.2%		President and Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks David Kirn traded

• $FDMT

Frequently asked questions

Has David Kirn been buying or selling stock?

David Kirn has 0 open-market purchases and 1 open-market sale on file, net -$1.20M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was David Kirn's latest insider trade?

disposed of 114.75K shares of $FDMT on Jun 22, 2026 at $10.47.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.